Literature DB >> 20685853

Conformation of the mineralocorticoid receptor N-terminal domain: evidence for induced and stable structure.

Katharina Fischer1, Sharon M Kelly, Kate Watt, Nicholas C Price, Iain J McEwan.   

Abstract

The mineralocorticoid receptor (MR) binds the steroid hormones aldosterone and cortisol and has an important physiological role in the control of salt homeostasis. Regions of the protein important for gene regulation have been mapped to the amino-terminal domain (NTD) and termed activation function (AF)1a, AF1b, and middle domain (MD). In the present study, we used a combination of biophysical and biochemical techniques to investigate the folding and function of the MR-NTD transactivation functions. We demonstrate that MR-AF1a and MR-MD have relatively little stable secondary structure but have the propensity to form α-helical conformation. Induced folding of the MR-MD enhanced protein-protein binding with a number of coregulatory proteins, including the coactivator cAMP response element-binding protein-binding protein and the corepressors SMRT and RIP140. By contrast, the MR-AF1b domain appeared to have a more stable conformation consisting predominantly of β-secondary structure. Furthermore, MR-AF1b specifically interacted with the TATA-binding protein, via an LxxLL-like motif, in the absence of induced folding. Together, these data suggest that the MR-NTD contains a complex transactivation system made up of distinct structural and functional domains. The results are discussed in the context of the induced folding paradigm for steroid receptor NTDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685853      PMCID: PMC5417395          DOI: 10.1210/me.2010-0005

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  58 in total

Review 1.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

Review 2.  Structure-function relationships in the mineralocorticoid receptor.

Authors:  Jyotsna B Pippal; Peter J Fuller
Journal:  J Mol Endocrinol       Date:  2008-09-19       Impact factor: 5.098

3.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

4.  The acidic activation domains of the GCN4 and GAL4 proteins are not alpha helical but form beta sheets.

Authors:  M Van Hoy; K K Leuther; T Kodadek; S A Johnston
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

Review 5.  Mechanisms of mineralocorticoid action.

Authors:  Peter J Fuller; Morag J Young
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

6.  Regulation of the amino-terminal transcription activation domain of progesterone receptor by a cofactor-induced protein folding mechanism.

Authors:  Suzanne E Wardell; Stanley C Kwok; Lori Sherman; Robert S Hodges; Dean P Edwards
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

7.  Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling.

Authors:  O C Meijer; E Kalkhoven; S van der Laan; P J Steenbergen; S H Houtman; T F Dijkmans; D Pearce; E R de Kloet
Journal:  Endocrinology       Date:  2004-11-24       Impact factor: 4.736

8.  Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9.

Authors:  Kenichi Yokota; Hirotaka Shibata; Isao Kurihara; Sakiko Kobayashi; Noriko Suda; Ayano Murai-Takeda; Ikuo Saito; Hirochika Kitagawa; Shigeaki Kato; Takao Saruta; Hiroshi Itoh
Journal:  J Biol Chem       Date:  2006-11-14       Impact factor: 5.157

9.  Induced alpha-helix structure in the aryl hydrocarbon receptor transactivation domain modulates protein-protein interactions.

Authors:  Kate Watt; Thomas J Jess; Sharon M Kelly; Nicholas C Price; Iain J McEwan
Journal:  Biochemistry       Date:  2005-01-18       Impact factor: 3.162

10.  Antagonism in the human mineralocorticoid receptor.

Authors:  J Fagart; J M Wurtz; A Souque; C Hellal-Levy; D Moras; M E Rafestin-Oblin
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more
  17 in total

Review 1.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

2.  Regulation of the structurally dynamic N-terminal domain of progesterone receptor by protein-induced folding.

Authors:  Raj Kumar; Carmen M Moure; Shagufta H Khan; Celetta Callaway; Sandra L Grimm; Devrishi Goswami; Patrick R Griffin; Dean P Edwards
Journal:  J Biol Chem       Date:  2013-08-30       Impact factor: 5.157

Review 3.  Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges.

Authors:  S Stoney Simons; Dean P Edwards; Raj Kumar
Journal:  Mol Endocrinol       Date:  2013-11-27

Review 4.  Structural dynamics, intrinsic disorder, and allostery in nuclear receptors as transcription factors.

Authors:  Vincent J Hilser; E Brad Thompson
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

Review 5.  The multifaceted mineralocorticoid receptor.

Authors:  Elise Gomez-Sanchez; Celso E Gomez-Sanchez
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

6.  Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells.

Authors:  Grant Buchanan; Eleanor F Need; Jeffrey M Barrett; Tina Bianco-Miotto; Vanessa C Thompson; Lisa M Butler; Villis R Marshall; Wayne D Tilley; Gerhard A Coetzee
Journal:  Mol Cell Endocrinol       Date:  2011-06-01       Impact factor: 4.102

7.  Influence of domain interactions on conformational mobility of the progesterone receptor detected by hydrogen/deuterium exchange mass spectrometry.

Authors:  Devrishi Goswami; Celetta Callaway; Bruce D Pascal; Raj Kumar; Dean P Edwards; Patrick R Griffin
Journal:  Structure       Date:  2014-06-05       Impact factor: 5.006

Review 8.  Variable steroid receptor responses: Intrinsically disordered AF1 is the key.

Authors:  S Stoney Simons; Raj Kumar
Journal:  Mol Cell Endocrinol       Date:  2013-06-17       Impact factor: 4.102

9.  Drugging the Undruggable: Targeting the N-Terminal Domain of Nuclear Hormone Receptors.

Authors:  Marianne D Sadar
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

10.  An androgen receptor N-terminal domain antagonist for treating prostate cancer.

Authors:  Jae-Kyung Myung; Carmen A Banuelos; Javier Garcia Fernandez; Nasrin R Mawji; Jun Wang; Amy H Tien; Yu Chi Yang; Iran Tavakoli; Simon Haile; Kate Watt; Iain J McEwan; Stephen Plymate; Raymond J Andersen; Marianne D Sadar
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.